Viokase - V Powder
Activated whole raw pancreas; a pancreatic enzyme concentrate of porcine origin containing standardized amylase, protease and lipase activities plus esterases, peptidases, nucleases and elastase. For use in dogs and cats as a digestive aid, or as replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.
VIOKASE®-V
Zoetis
Tablet 425 mg
Powder
WHOLE PANCREAS
NOT AN EXTRACT
NOT ENTERIC COATED
Each 425 mg tablet contains:
|
Lipase
|
9,000 USP units
|
|
Protease
|
57,000 USP units
|
|
Amylase
|
64,000 USP units
|
Each 2.8 grams (1 teaspoonful) of powder contains:
|
Lipase
|
71,400 USP units
|
|
Protease
|
388,000 USP units
|
|
Amylase
|
460,000 USP units
|
CAUTION
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
DESCRIPTION
VIOKASE-V is activated whole raw pancreas; a pancreatic enzyme concentrate of porcine origin containing standardized amylase, protease and lipase activities plus esterases, peptidases, nucleases and elastase.
BACKGROUND INFORMATION
A review of the literature over the past 20 years, together with clinical experience, prompts the conclusion that pancreatitis is an important disease in the dog. Evidence of the disease was observed in approximately 3% of a series of dogs necropsied at the Angell Memorial Animal Hospital. Others have classified disease of the pancreas into 4 distinctive categories: acute necrotic pancreatitis; subacute or chronic pancreatitis; pancreatic fibrosis; and collapse or atrophy of the acinar pancreatic tissue. Only acute and chronic pancreatitis is readily recognized clinically.
INDICATIONS
As a digestive aid; replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.
PRECAUTIONS
Discontinue use in animals with symptoms of sensitivity.
TREATMENT IN ACUTE AND CHRONIC PANCREATITIS
The most important aspect of the treatment of acute pancreatitis is initiation of vigorous therapy aimed at combating pain and shock, restoring blood volume, blood pressure and renal function, with reducing pancreatic secretions and combating secondary infection of necrotic tissue. Animals surviving an acute attack should be placed on a bland and easily digested diet (such as Prescription Diet®, i/d) and supplemented with VIOKASE-V.
In chronic pancreatitis, replacement therapy must be given for the duration of the animal’s life. Three daily feedings of a bland and easily digested diet containing sufficient quantities of good quality proteins and carbohydrates and low levels of fat are recommended (i.e., Prescription Diet, i/d). VIOKASE-V is given with each meal at a dosage level sufficient to keep the feces normal.
